Intuitive Surgical stock costs EUR 382.35 as Q2 revenue rose 19 percent

Published on 10/19/2026 at 10:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock costs EUR 382.35 on October 19, 2026. Q2 revenue reached USD 2.89 billion, up 19 percent, before October 20 results.

Revenue growth before the next report

Second-quarter revenue reached USD 2.89 billion, up 19 percent on July 16, 2026.
Intuitive Surgical expects its next earnings report on October 20, 2026, with USD 2.91 billion in consensus revenue.
Intuitive Surgical stock trades at EUR 382.35 at 10:03 a.m. CEST at Lang & Schwarz on October 19, 2026.

Aquarellillustration eines modernen Technologiecampus mit Palmen und Glasgebäuden in Sunnyvale — Aquarellmalerei des Firmensitzes in Sunnyvale zeigt Intuitive Surgical Inc. (US46120E6023) mit modernem Campus und Palmen, Illustration mit AI erstellt.

Intuitive Surgical stock (ISIN US46120E6023) was trading at EUR 382.35 at Lang & Schwarz on October 19, 2026, at 10:03 a.m. CEST. The company is heading toward its third-quarter report on October 20, while second-quarter revenue had reached USD 2.89 billion, up 19 percent year over year, according to Yahoo Finance.

Three milestones shape expectations

On July 16, 2026, Intuitive Surgical reported second-quarter revenue of USD 2.89 billion and GAAP net income of USD 818.10 million, compared with USD 658.00 million a year earlier, according to Yahoo Finance. Total procedures increased 16 percent, with da Vinci procedures up 15 percent and Ion procedures up 36 percent.

On September 8, 2026, Intuitive Surgical highlighted a meta-analysis covering 13 benign conditions that found improved patient outcomes associated with da Vinci surgery, according to its investor page. The company had also maintained full-year da Vinci procedure growth guidance of 13.50 percent to 15.50 percent for 2026.

On October 20, 2026, Intuitive Surgical is scheduled to report third-quarter results and hold its earnings call, according to Intuitive Surgical. A market estimate cited by FinancialContent calls for USD 2.91 billion in revenue, implying 15.60 percent year-over-year growth.

What does the next report test?

The central question is whether procedure growth can stay near the company guidance range after U.S. da Vinci growth moderated to 12 percent in the second quarter. The international business and the recurring revenue base remain important indicators because recurring revenue reached USD 2.47 billion, or 85 percent of second-quarter sales, according to Yahoo Finance.

Stock holds above EUR 380

At Lang & Schwarz, the stock was trading at EUR 382.35 on October 19, 2026, at 10:03 a.m. CEST. Intuitive Surgical is listed on Nasdaq under ticker ISRG and operates in healthcare medical instruments and supplies.

The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.